In this study, the BRAF V600 mutation incidence was found in five patients (1.3%) among all cases of non-small cell carcinoma, and the BRAF V600E mutation was present in three patients (0.8%) with adenocarcinoma. This evidence concerns the gene BRAF and adenocarcinoma.